Cubist Systematic Strategies’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.44M | Buy |
446,747
+179,485
| +67% | +$1.87M | 0.02% | 1033 |
|
|
2025
Q2 | $2.65M | Sell |
267,262
-389,279
| -59% | -$4.1M | 0.01% | 1408 |
|
|
2025
Q1 | $8.52M | Buy |
656,541
+461,980
| +237% | +$6.11M | 0.05% | 565 |
|
|
2024
Q4 | $2.48M | Buy |
+194,561
| New | +$2.35M | 0.02% | 1229 |
|
|
2024
Q1 | – | Sell |
-8,945
| Closed | -$125K | – | 3858 |
|
|
2023
Q4 | $125K | Buy |
+8,945
| New | +$124K | ﹤0.01% | 3131 |
|
|
2023
Q1 | – | Sell |
-90,947
| Closed | -$968K | – | 4016 |
|
|
2022
Q4 | $968K | Sell |
90,947
-113,568
| -56% | -$1.32M | 0.01% | 2479 |
|
|
2022
Q3 | $2.13M | Buy |
204,515
+88,302
| +76% | +$1.15M | 0.01% | 1947 |
|
|
2022
Q2 | $1.46M | Buy |
116,213
+25,139
| +28% | +$267K | 0.01% | 2150 |
|
|
2022
Q1 | $987K | Sell |
91,074
-162,333
| -64% | -$1.97M | 0.01% | 2032 |
|
|
2021
Q4 | $3.56M | Buy |
253,407
+133,417
| +111% | +$2.2M | 0.03% | 887 |
|
|
2021
Q3 | $2.31M | Buy |
119,990
+87,791
| +273% | +$1.17M | 0.03% | 917 |
|
|
2021
Q2 | $317K | Sell |
32,199
-21,458
| -40% | -$195K | ﹤0.01% | 2290 |
|
|
2021
Q1 | $527K | Buy |
+53,657
| New | +$442K | 0.01% | 1925 |
|
|
2020
Q4 | – | Sell |
-129,205
| Closed | -$558K | – | 2588 |
|
|
2020
Q3 | $558K | Buy |
+129,205
| New | +$922K | 0.01% | 1686 |
|
|
2020
Q1 | – | Sell |
-79,098
| Closed | -$452K | – | 2233 |
|
|
2019
Q4 | $452K | Buy |
79,098
+68,191
| +625% | +$365K | 0.01% | 1604 |
|
|
2019
Q3 | $39K | Sell |
10,907
-50,678
| -82% | -$196K | ﹤0.01% | 2079 |
|
|
2019
Q2 | $246K | Buy |
61,585
+20,476
| +50% | +$119K | ﹤0.01% | 1932 |
|
|
2019
Q1 | $301K | Buy |
41,109
+16,415
| +66% | +$160K | 0.01% | 1494 |
|
|
2018
Q4 | $226K | Buy |
24,694
+9,780
| +66% | +$108K | 0.01% | 1457 |
|
|
2018
Q3 | $185K | Buy |
14,914
+14,574
| +4,286% | +$197K | 0.01% | 1435 |
|
|
2018
Q2 | $5K | Sell |
340
-5,080
| -94% | -$87.8K | ﹤0.01% | 1739 |
|
|
2018
Q1 | $108K | Buy |
5,420
+2,125
| +64% | +$36.7K | 0.01% | 1578 |
|
|
2017
Q4 | $62K | Sell |
3,295
-2,109
| -39% | -$42.3K | ﹤0.01% | 1756 |
|
|
2017
Q3 | $116K | Sell |
5,404
-5,089
| -48% | -$80.5K | 0.01% | 1598 |
|
|
2017
Q2 | $101K | Buy |
10,493
+3,700
| +54% | +$24K | 0.01% | 1451 |
|
|
2017
Q1 | $40K | Buy |
+6,793
| New | +$32.7K | ﹤0.01% | 1496 |
|
|
2016
Q4 | – | Sell |
-10,286
| Closed | -$108K | – | 1753 |
|
|
2016
Q3 | $108K | Buy |
10,286
+10,034
| +3,982% | +$144K | 0.01% | 1447 |
|
|
2016
Q2 | $4K | Sell |
252
-67
| -21% | -$1.15K | ﹤0.01% | 1675 |
|
|
2016
Q1 | $6K | Buy |
+319
| New | +$6.45K | ﹤0.01% | 1562 |
|
|
2015
Q4 | – | Sell |
-21,963
| Closed | -$539K | – | 1796 |
|
|
2015
Q3 | $539K | Sell |
21,963
-10,185
| -32% | -$288K | 0.03% | 919 |
|
|
2015
Q2 | $753K | Buy |
32,148
+9,421
| +41% | +$205K | 0.04% | 731 |
|
|
2015
Q1 | $510K | Buy |
+22,727
| New | +$436K | 0.03% | 923 |
|
Other funds holding DVAX
DTC
CC
Cubist Systematic Strategies's DVAX Position: Q3 2025 in Review
Cubist Systematic Strategies increased its Dynavax Technologies (DVAX) stake by 67% in Q3 2025, buying an estimated $1.87M and bringing the position to 446,747 shares worth $4.44M. The position accounts for 0.02% of the portfolio, ranked #1033.
Cubist Systematic Strategies first reported a position in DVAX in Q1 2015 and has held it in 32 quarters since. The position peaked at $8.52M in Q1 2025. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.
- Cubist Systematic Strategies held 446,747 shares of Dynavax Technologies worth $4.44M as of Q3 2025.
- Cubist Systematic Strategies bought 179,485 Dynavax Technologies shares in Q3 2025, an estimated $1.87M.
- Dynavax Technologies made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1033 holding.
- Cubist Systematic Strategies first reported a position in Dynavax Technologies in Q1 2015 and has held it in 32 quarters since.
- Cubist Systematic Strategies's Dynavax Technologies position peaked at $8.52M in Q1 2025.
- 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.